Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002546 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
A Phase 3 study of Sarcoma, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 216
- Enrollment target
- 20
- Study locations
NCT00002546: Completed Phase 3 study of Sarcoma, sponsored by Gynecologic Oncology Group.
NCT00002546 is a Phase 3 study of Sarcoma that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 216 participants, below the 919-participant average among 122 other Sarcoma trials with a reported enrollment target (76% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002546, a Phase 3 study of Sarcoma, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 216 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy is more effective than combination chemotherapy in treating patients with cancer of the uterus. PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared to combination chemotherapy in treating patients with cancer of the uterus.
Conditions Studied
Interventions
- DRUG cisplatin
- RADIATION radiation therapy
- DRUG ifosfamide
- PROCEDURE adjuvant therapy
Study Locations (20)
Illinois
- Rush University Medical Center - Chicago
- MBCCOP - University of Illinois at Chicago - Chicago
- University of Chicago Cancer Research Center - Chicago
- CCOP - Central Illinois - Decatur
- CCOP - Evanston - Evanston
- - Hinsdale
- CCOP - Carle Cancer Center - Urbana
Indiana
- Indiana University Cancer Center - Indianapolis
- CCOP - Northern Indiana CR Consortium - South Bend
- Saint Joseph Regional Medical Center - South Bend
California
- Women's Cancer Center - Los Gatos - Los Gatos
- Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center - Orange
Alabama
- University of Alabama at Birmingham Comprehensive Cancer Center - Birmingham
Arizona
- CCOP - Western Regional, Arizona - Phoenix
Colorado
- University of Colorado Cancer Center at University of Colorado Health Sciences Center - Denver
Delaware
- CCOP - Christiana Care Health Services - Newark
District of Columbia
- Walter Reed Army Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 1993-12 |
| Phase | Phase 3 |
What the finished NCT00002546 record still lists
NCT00002546 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 919-participant average among 122 other Sarcoma trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 4 interventions - of which cisplatin is the first listed.
NCT00002546 names 20 study sites across 11 states, led by Illinois, Indiana, California.
Frequently Asked Questions
What is clinical trial NCT00002546 about?
NCT00002546 is a clinical study titled "Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy is more effective than combination chemotherapy in treating patients ...
What is the current status of trial NCT00002546?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 216 participants. The study started on 1993-12.
What conditions does trial NCT00002546 study?
This clinical trial studies the following conditions: Sarcoma.
What interventions are being tested in trial NCT00002546?
The interventions under investigation include: cisplatin (DRUG), radiation therapy (RADIATION), ifosfamide (DRUG), adjuvant therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00002546?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002546 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00002546's enrollment target sits among peer trials
216 28th of 122 higher than 95 of 122 other Sarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
ACTIVE NOT RECRUITING · Phase 3
-
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
COMPLETED · Phase 3
-
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
COMPLETED · Phase 3
-
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families
COMPLETED · Phase 3
-
Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
COMPLETED · Phase 3
-
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia